How Lombardi was paid
$6.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Incentive | Total |
|---|---|---|---|
| Ronald M. LombardiPresident, Chief Executive Officer and Chair of the Board | $1,000,000 | $1,134,000 | $6,193,019 |
| Christine SaccoChief Financial Officer and Chief Operating Officer | $700,000 | $595,298 | — |
| Adel MekhailExecutive Vice President of Marketing and Sales | $528,000 | $312,365 | — |
| William C. P’PoolSenior Vice President, General Counsel and Corporate Secretary | $546,000 | $296,096 | — |
| Jeffrey ZerilloSenior Vice President, Operations | $370,000 | $145,928 | — |
What changed and why
- $6.2M$6,193,019 CEO total compensation was reported for 2025.
- 98.6%$1,134,000 CEO annual incentive payout represented 98.6% of target bonus.
- 15%$595,298 CFO and COO annual incentive payout included a 15% individual performance adjustment.
- 10%$296,096 General Counsel annual incentive payout included a 10% individual performance adjustment.
- 75%$4,000,000 was the CEO’s targeted FY2025 equity award value, allocated 75% to performance stock units.
- $82,85075:1 was the 2025 CEO-to-median-employee pay ratio, based on median employee compensation of $82,850.
Other Prestige Consumer Healthcare proxy statements
- 2026 proxy statement
Ronald M. Lombardi paid $6M (-3% on the year), pay ratio 54:1.
Filed Jun 29, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.